Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

World’s largest solar mural turns 34,500 sqft wall into power generator

The SunRise Building, a residential complex in Alberta, Canada, has established a Guinness World Record for the largest solar panel mural.

The installation combines art with building-integrated photovoltaics (BIPV), contributing to the building’s energy supply. This project measures 34,500 square feet and provides 267 kW of solar capacity, powering the building’s common areas.

Study shows how brain-to-computer ‘electroceuticals’ can help restore cognition

Research led by Thilo Womelsdorf, professor of psychology and biomedical engineering at the Vanderbilt Brain Institute, could revolutionize how brain-computer interfaces are used to treat disorders of memory and cognition.

The study, “Adaptive reinforcement learning is causally supported by and striatum,” was published June 10, 2025, in the journal Neuron.

According to researchers, neurologists use electrical (BCIs) to help patients with Parkinson’s disease and when drugs and other rehabilitative interventions are not efficient. For these disorders, researchers say brain-computer interfaces have become electroceuticals that substitute pharmaceuticals by directly modulating dysfunctional brain signals.

‘Weird shading’ tricks the brain into seeing 3D forms from simple lines

Shading brings 3D forms to life, beautifully carving out the shape of objects around us. Despite the importance of shading for perception, scientists have long been puzzled about how the brain actually uses it. Researchers from Justus-Liebig-University Giessen and Yale University recently came out with a surprising answer.

Previously, it has been assumed that one interprets shading like a physics-machine, somehow “reverse-engineering” the combination of and lighting that would recreate the shading we see. Not only is this extremely challenging for advanced computers, but the visual is not designed to solve that sort of problem. So, these researchers decided to start instead by considering what is known about the brain when it first gets signals from the eye.

“In some of the first steps of visual processing, the brain passes the image through a series of ‘edge-detectors,’ essentially tracing it like an etch-a-sketch,” Professor Roland W. Fleming of Giessen explains. “We wondered what shading patterns would look like to a brain that’s searching for lines.” This insight led to an unexpected, but clever short-cut to the shading inference problem.

A parasitic worm may help rebuild blue crab populations in the Chesapeake Bay

Parasitic, egg-eating worms might sound like the stuff of nightmares, but they’re simply a fact of life for blue crabs in the Chesapeake Bay.

Interestingly, a new study published in the journal PLOS One by researchers at William & Mary’s Batten School & VIMS suggests these worms could serve as a valuable biomarker for managing the fishery.

The most recent Winter Dredge Survey, conducted by the Batten School of Coastal & Marine Sciences & VIMS in collaboration with Maryland’s Department of Natural Resources, recorded historically low numbers of in the Chesapeake Bay. The findings have sparked concern among the fishery’s many stakeholders and highlight a need for new tools that can help balance economic and ecological priorities—this study may help with that.

More misfolded proteins than previously known may contribute to Alzheimer’s and dementia

For decades, the story of Alzheimer’s research has been dominated by a battle between A-beta and tau amyloids, both of which can kill neurons and impact the brain’s ability to function. A new study suggests, however, that these sticky brain plaques may not be operating alone.

Johns Hopkins University researchers have identified more than 200 types of in rats that could be associated with age-related cognitive decline.

The findings could lead the way to finding new therapeutic targets and treatments in humans that could provide relief for the millions of people over 65 who suffer from Alzheimer’s, dementia, or other diseases that rob them of their memories and independence as they age.